Viatris Inc (VTRS)
11.62
+0.16
(+1.44%)
USD |
NASDAQ |
Nov 05, 16:00
11.62
0.00 (0.00%)
After-Hours: 16:14
Viatris Price: 11.62 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 11.59 | 11.70 | 11.42 | 11.46 | 4.432M |
Nov 01, 2024 | 11.67 | 11.76 | 11.58 | 11.62 | 5.349M |
Oct 31, 2024 | 11.88 | 11.90 | 11.59 | 11.60 | 8.053M |
Oct 30, 2024 | 11.67 | 11.96 | 11.65 | 11.89 | 4.765M |
Oct 29, 2024 | 11.69 | 11.78 | 11.63 | 11.74 | 4.803M |
Oct 28, 2024 | 11.52 | 11.79 | 11.48 | 11.76 | 5.020M |
Oct 25, 2024 | 11.56 | 11.68 | 11.43 | 11.44 | 3.180M |
Oct 24, 2024 | 11.56 | 11.64 | 11.42 | 11.48 | 4.068M |
Oct 23, 2024 | 11.63 | 11.72 | 11.49 | 11.55 | 3.470M |
Oct 22, 2024 | 11.54 | 11.71 | 11.52 | 11.67 | 4.077M |
Oct 21, 2024 | 11.76 | 11.81 | 11.57 | 11.57 | 3.714M |
Oct 18, 2024 | 11.61 | 11.77 | 11.51 | 11.76 | 4.684M |
Oct 17, 2024 | 11.82 | 11.82 | 11.66 | 11.71 | 4.003M |
Oct 16, 2024 | 11.85 | 11.89 | 11.72 | 11.82 | 4.355M |
Oct 15, 2024 | 11.39 | 11.93 | 11.36 | 11.84 | 6.746M |
Oct 14, 2024 | 11.37 | 11.40 | 11.28 | 11.39 | 5.051M |
Oct 11, 2024 | 11.37 | 11.45 | 11.32 | 11.38 | 4.219M |
Oct 10, 2024 | 11.42 | 11.46 | 11.24 | 11.33 | 4.839M |
Oct 09, 2024 | 11.36 | 11.46 | 11.29 | 11.41 | 4.210M |
Oct 08, 2024 | 11.33 | 11.43 | 11.24 | 11.32 | 4.412M |
Oct 07, 2024 | 11.60 | 11.64 | 11.33 | 11.33 | 4.618M |
Oct 04, 2024 | 11.50 | 11.65 | 11.48 | 11.59 | 4.015M |
Oct 03, 2024 | 11.39 | 11.45 | 11.28 | 11.43 | 7.017M |
Oct 02, 2024 | 11.48 | 11.52 | 11.33 | 11.47 | 6.956M |
Oct 01, 2024 | 11.62 | 11.66 | 11.41 | 11.49 | 6.821M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.48
Minimum
Sep 27 2022
22.85
Maximum
Feb 05 2020
13.07
Average
11.94
Median
Jan 30 2023
Price Benchmarks
Lexicon Pharmaceuticals Inc | 1.185 |
Eli Lilly and Co | 806.37 |
Amgen Inc | 319.23 |
Gilead Sciences Inc | 90.20 |
Perspective Therapeutics Inc | 12.34 |
Price Related Metrics
PS Ratio | 0.9186 |
Price to Book Value | 0.7105 |
Price to Free Cash Flow | 7.431 |
Earnings Yield | -4.73% |
Market Cap | 13.87B |
Operating PE Ratio | 36.40 |